The new cash infusion is to be used to strengthen its balance sheet as negotiations take place with potential commercial partners for its flagship drug, Lupuzor.
ImmuPharma chairman 'delighted' with £4.1mln fund raise support
Quick facts: ImmuPharma PLC
Price: 15.02 GBX
Market Cap: £25.14 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ImmuPharma PLC named herein, including the promotion by the Company of ImmuPharma PLC in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE